Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Facet Biotech Calls Biogen Offer Too Low

September 8, 2009 4:33 am | News | Comments

NEW YORK (AP) — Facet Biotech Corp. on Tuesday turned down a $356 million buyout offer from drug development partner Biogen Idec Inc., saying it doesn't properly value the company and its developing products. On Friday, Cambridge, Mass.-based Biogen said it would pay $14.

TOPICS:

FDA Says Glaxo Vaccine Blocks Cancer-Causing Virus

September 4, 2009 7:57 am | News | Comments

WASHINGTON (AP) — The Food and Drug Administration says a vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer.

TOPICS:

King, Acura Say FDA Does Not Need New Acurox Trial

September 4, 2009 6:29 am | News | Comments

NEW YORK (AP) — King Pharmaceuticals Inc. and Acura Pharmaceuticals Inc. said Friday they don't expect to have to run new clinical trials of an abuse-resistant pain drug in order to gain Food and Drug Administration approval.

TOPICS:
Advertisement

Study: New Treatment May Combat Drug-Resistant Flu

September 4, 2009 4:50 am | News | Comments

MARIA CHENG AP Medical Writer LONDON (AP) — A new and unlicensed treatment for swine flu could be used in patients who have Tamiflu-resistant viruses, doctors say.

TOPICS:

Becton, Dickinson Gets $52 million Government Flu Contract

September 4, 2009 4:47 am | News | Comments

FRANKLIN LAKES, N.J. (AP) — Becton, Dickinson and Co. said Thursday it received a $52 million order from the federal government to supply syringes, needles and other supplies for swine flu shots.

U.S. Treasury Department Sanctions 6 Mexicans Accused of Meth Trade Ties

September 4, 2009 4:44 am | News | Comments

MEXICO CITY (AP) — The U.S. Treasury Department has imposed sanctions on six Mexicans linked to a pharmaceutical company that allegedly diverted precursor chemicals to a methamphetamine trafficking gang.

Takeda Receives FDA Complete Response Letter for the InvestigationalFixed-Dose Combination of alogliptin and ACTOS for theTreatment of Type 2 Diabetes

September 4, 2009 4:40 am | News | Comments

TakedaPharmaceutical Company Limited has announced that its whollyowned subsidiary, Takeda Global Research & Development Center, Inc. (U.S.

TOPICS:

Array BioPharma's Rheumatoid Arthritis Drug Misses Study Goal

September 4, 2009 4:35 am | News | Comments

BOULDER, Colo. (AP) — Shares of Array BioPharma Inc. tumbled in premarket trading Friday after the drug maker said its experimental rheumatoid arthritis treatment didn't prove more effective than a placebo in reducing symptoms in a midstage study. The stock fell 86 cents, or 23 percent, to $2.92.

TOPICS:
Advertisement

Court Rules Against Elan In Biogen Case

September 4, 2009 4:33 am | News | Comments

NEW YORK (AP) — Elan says a federal judge ruled it violated the terms of an agreement with Biogen Idec to market the multiple sclerosis treatment Tysabri when it struck a separate deal to collaborate with Johnson & Johnson. Elan Corp.

TOPICS:

Court Rules Agains Elan In Biogen Case

September 4, 2009 4:32 am | News | Comments

NEW YORK (AP) — Elan says a federal judge ruled it violated the terms of an agreement with Biogen Idec to market the multiple sclerosis treatment Tysabri when it struck a separate deal to collaborate with Johnson & Johnson. Elan Corp.

TOPICS:

Allegheny Bradford Expands Scope With New Facility

September 3, 2009 7:24 am | News | Comments

By PATRICK CONNOLLY Era Reporter p.connolly@bradfordera.com Allegheny Bradford Corp. opened the

TOPICS:

Akela Pharma Announces Restructuring, Cuts One-Third of Workforce

September 3, 2009 6:53 am | News | Comments

Akela Pharma Inc. is cutting about a third of its workforce as it undergoes a corporate restructuring to focus on its key cancer pain treatment Fentanyl Taifun.

TOPICS:

Merck Eye Drug Salutan Launched in UK and Spain

September 3, 2009 6:23 am | News | Comments

WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said Thursday it launched the eye pressure drug Saflutan in the U.K. and Spain. Saflutan is intended to treat elevated pressure inside the eye in patients with primary open-angle glaucoma — the most common type of glaucoma and ocular hypertension.

TOPICS:

Low Differential Pressure Transmitter Ideal For Critical Air Flow Applications

September 3, 2009 6:10 am | Product Releases | Comments

The DXLdp low differential pressure transmitter is a favorite for critical air flow, room pressure and air handler management applications. Equipped with the SpoolCal option, the DXLdp can be validated, zeroed and calibrated while on line, without ever having to disconnect the pressure tubing.

FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines

September 3, 2009 5:51 am | News | Comments

Makers of approved drugsand biologics generally are meeting their regulatory obligations and completetheir postmarketing studies in a timely manner, according to a study releasedtoday by the U.S. Food and Drug Administration.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading